Long speculated to slow or even reverse aging in off-label use, the generic drugs metformin and rapamycin are getting formal clinical trials this year. (Worth magazine)
Long speculated to slow or even reverse aging in off-label use, the generic drugs metformin and rapamycin are getting formal clinical trials this year. (Worth magazine)